You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 5, May 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Sodium Salicylate and Indomethacin on Methotrexate-Serum Albumin Binding

J. Richard Taylor, MD; Kenneth M. Halprin, MD

Arch Dermatol. 1977;113(5):588-591.


Abstract

• Approximately 60% of methotrexate in serum is protein bound and this binding occurs primarily to serum albumin. The fraction of methotrexate bound remains relatively constant despite changes in free methotrexate concentrations over the range observed clinically.

Indomethacin did not influence methotrexate-albumin binding, but salicylate in therapeutic concentrations produced a 20% to 60% decrease in binding. The clinical significance of these findings for patients requiring concomitant methotrexate and salicylate is discussed.

(Arch Dermatol 113:588-591, 1977)



Author Affiliations

From the Dermatology Service, Miami Veterans Administration Hospital and the Department of Dermatology, University of Miami School of Medicine, Miami.


Footnotes

Accepted for publication Oct 13, 1976.

Reprint requests to VA Hospital, Dermatology Service, 1201 NW 16 St, Miami 33125 (Dr Taylor).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinically Significant Drug-Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: Profiling and Comparison of Two Drug Compendia
Wong et al.
The Annals of Pharmacotherapy 2008;42:1737-1748.
ABSTRACT | FULL TEXT  

Characterization of Methotrexate Transport and Its Drug Interactions with Human Organic Anion Transporters
Takeda et al.
J. Pharmacol. Exp. Ther. 2002;302:666-671.
ABSTRACT | FULL TEXT  

Methotrexate-Associated, Early-Onset Pancytopenia in Rheumatoid Arthritis
Doolittle et al.
Arch Intern Med 1989;149:1430-1431.
ABSTRACT  

Pancytopenia Following Low-Dose Oral Methotrexate Therapy for Psoriasis
Shupack and Webster
JAMA 1988;259:3594-3596.
ABSTRACT  

Division of Physician-Provider Time Between Ambulatory and In-Bed Patients in the Various Medical Specialties-Reply
Clair et al.
Arch Intern Med 1986;146:603-603.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.